| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | 0.0095 | 0.9 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.9 |
| mRNA | pitstop2 | CTRPv2 | pan-cancer | AAC | 0.0051 | 0.9 |
| mRNA | Vinorelbine | GDSC1000 | pan-cancer | AAC | 0.0039 | 0.9 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | 0.0038 | 0.9 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | 0.0049 | 0.9 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.0039 | 0.9 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.0035 | 0.9 |
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0033 | 0.9 |